Close Menu

NEW YORK – Roche on Wednesday reported essentially flat year-over-year sales for its diagnostics division in the first quarter of 2020, despite a sharp uptick in its molecular diagnostics sales.

Roche as a whole, including both its pharmaceutical and diagnostics divisions, had CHF 15.14 billion ($15.65 billion) in sales in the quarter, up 7 percent from CHF 14.83 billion in Q1 of 2019.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Researchers are developing a breath test to determine how severe patients' methylmalonic acidemia disease is, FierceBiotech reports.

NPR reports that vaccine developers are working on SARS-CoV-2 vaccines that are easier to store or administer than the current crop.

Reuters reports that France is to recommend that people under 55 who received one dose of AstraZeneca's SARS-CoV-2 vaccine receive a different vaccine for their second dose.